BELINDA BAGBY: Open Payments
NPI 1083042956 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 18 payments from 6 companies in 2025. Trend: 2023 $18,142 · 2024 $17,688 · 2025 $2,340
Speaker / faculty: $1,925Food & beverage: $328Travel & lodging: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $2,084 |
| E.R. Squibb & Sons, L.L.C. | 6 | $146 |
| Janssen Pharmaceuticals, Inc | 1 | $64 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, COBENFY, SPRAVATO, INGREZZA, Qelbree, CAPLYTA.
Industry payments across KS — which companies pay providers there.
